Source comparison
Best BPC-157 Dosage Gut Health 2026: Protocol Comparison
Acute Gastric Protection 250–350mcg Oral (capsule) 2–3 weeks NSAID-induced ulcers, stress gastritis Best for upper GI; shorter cycle adequate for surface lesions without deep tissue damage Inflammatory Bowel Support 400–500mcg Subcutaneous (split dose) 4–6 wee
This comparison does not assign a generated winner or score.
- Acute Gastric Protection
- 250–350mcg
- Oral (capsule)
- 2–3 weeks
- NSAID-induced ulcers, stress gastritis
- Best for upper GI; shorter cycle adequate for surface lesions without deep tissue damage
- Inflammatory Bowel Support
- 400–500mcg
- Subcutaneous (split dose)
- 4–6 weeks
- Colitis models, Crohn's analogs, barrier dysfunction
- Sustained systemic exposure needed; longer cycle addresses transmural inflammation and tight junction repair
- Leaky Gut / Barrier Restoration
- 250–400mcg
- Oral or subcutaneous
- 6–8 weeks
- Intestinal permeability models, post-antibiotic damage
- Extended cycle required for zonulin normalization and claudin/occludin expression; oral may offer direct mucosal contact benefit
- Post-Surgical Anastomosis Healing
- 500mcg
- Subcutaneous
- 3–4 weeks
- Surgical wound models, fistula repair
- Higher dose justified by acute tissue trauma; angiogenesis critical in early healing phase